# DROSPIRENONE AND ETHINYL ESTRADIOL
> **ANDA078833** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 2011-11-28
## Drug
- **FDA Application Number:** ANDA078833
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DROSPIRENONE AND ETHINYL ESTRADIOL
- **Generic name:** DROSPIRENONE AND ETHINYL ESTRADIOL
- **Active ingredients:** DROSPIRENONE; ETHINYL ESTRADIOL
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2011-11-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=078833)
---
*AI Analytics · CC0 1.0*